Labbé A, Baudouin C
Service d'ophtalmologie 3, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France.
J Fr Ophtalmol. 2010 Apr;33(4):285-90. doi: 10.1016/j.jfo.2010.02.006. Epub 2010 Mar 20.
The treatments of glaucoma or ocular hypertension are associated with numerous ocular surface changes. Similarly, these ocular surface modifications directly impact the effectiveness of these therapies. The management of patients with glaucoma or ocular hypertension also suffering from dry eye syndrome needs to reduce eye drop-induced toxicity as well as a specific treatment for the ocular surface.
青光眼或高眼压症的治疗与众多眼表变化相关。同样，这些眼表改变也直接影响这些治疗方法的有效性。对同时患有青光眼或高眼压症以及干眼综合征的患者进行管理时，需要降低滴眼液引起的毒性，并针对眼表进行特定治疗。
